A research team at the University Medical Center Groningen (UMCG) in the Netherlands recently launched a three-year study into whether medicinal cannabis oil can help to regress liver-cancer tumours.
The pilot will involve 20 liver-cancer patients who have exhausted all other avenues of treatment but still have the liver function required to “process” cannabis oil. This type of study has not been carried out before, according to the research team. “It is pioneering in many ways,” said surgeon and lead researcher Maarten Nijkamp.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
